(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Synovial Sarcoma pipeline constitutes 15+ key companies continuously working towards developing 20+ Synovial Sarcoma treatment therapies, analysis of Clinical Trials,
Synovial Sarcoma Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Advenchen Lab, Ipsen, Daiichi Sankyo, EpiZyme, Merck, Immunocore, Novartis
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Sclerosis treatment therapies, analysis of Clinical Trials,
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Migraine pipeline constitutes 30+ key companies continuously working towards developing 30+ Migraine treatment therapies, analysis of Clinical Trials, Therapies, Mechanism
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, IgA Nephropathy pipeline constitutes 25+ key companies continuously working towards developing 30+ IgA Nephropathy treatment therapies, analysis of Clinical Trials,
Recently, CYCJET achieved a crucial breakthrough in its expansion into the Latin American market: In June 2025, Mexico’s largest juice
Beijing-On the evening of February 4, “The World TCM Heritage Odyssey,” co-hosted by Phoenix Satellite TV and Dong-E-E-Jiao, took place
Wealth Management Platform Market Mordor Intelligence has published a new report on the wealth management platform market, offering a comprehensive
Beycome, a tech-first, direct-to-consumer real estate platform, announced today the closing of a $2.5 million seed funding round. InsurTech Fund
Triple Negative Breast Cancer companies working in the market are Johnson & Johnson Private Limited, Cipla Inc, Abbott, AbbVie Inc,
DelveInsight’s, “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2025” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in
